Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Mar, 2016 | Pages:
48 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Aurigene Discovery Technologies Limited - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Aurigene Discovery Technologies Limited - Product Pipeline Review - 2016', provides an overview of the Aurigene Discovery Technologies Limited's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Aurigene Discovery Technologies Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Aurigene Discovery Technologies Limited - The report provides overview of Aurigene Discovery Technologies Limited including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Aurigene Discovery Technologies Limited's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Aurigene Discovery Technologies Limited's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Aurigene Discovery Technologies Limited's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Aurigene Discovery Technologies Limited - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Aurigene Discovery Technologies Limited's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 5 Aurigene Discovery Technologies Limited Snapshot 6 Aurigene Discovery Technologies Limited Overview 6 Key Information 6 Key Facts 6 Aurigene Discovery Technologies Limited - Research and Development Overview 7 Key Therapeutic Areas 7 Aurigene Discovery Technologies Limited - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Pipeline Products - Out-Licensed Products 14 Out-Licensed Products/Combination Treatment Modalities 15 Aurigene Discovery Technologies Limited - Pipeline Products Glance 16 Aurigene Discovery Technologies Limited - Early Stage Pipeline Products 16 IND/CTA Filed Products/Combination Treatment Modalities 16 Preclinical Products/Combination Treatment Modalities 17 Discovery Products/Combination Treatment Modalities 18 Aurigene Discovery Technologies Limited - Drug Profiles 19 AUR-012 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Drugs to Target Fab Pathway for Gram Negative Bacterial Infections 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 AEA-16 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 AU-1702014 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 AU-4869 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 CA-170 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 CA-4948 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Drugs for Cancer 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Drugs to Inhibit EZH2 for Cancer 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Small Molecule to Agonize ROR-Gamma for Inflammation and Oncology 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Small Molecules to Antagonize TIM-3 and PDL-1 for Oncology 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 AU-2439 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Drugs to Inhibit CDK9 and BET for Oncology 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Drugs to Inhibit MALT-1 for Oncology and Inflammation 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Drugs to Inhibit TDO and IDO for Oncology 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Small Molecule to Inhibit CDK7 for Oncology 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Small Molecule to Inhibit K-RAS for Oncology 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Small Molecules for Oncology 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Aurigene Discovery Technologies Limited - Pipeline Analysis 37 Aurigene Discovery Technologies Limited - Pipeline Products by Target 37 Aurigene Discovery Technologies Limited - Pipeline Products by Route of Administration 39 Aurigene Discovery Technologies Limited - Pipeline Products by Molecule Type 40 Aurigene Discovery Technologies Limited - Pipeline Products by Mechanism of Action 41 Aurigene Discovery Technologies Limited - Recent Pipeline Updates 43 Aurigene Discovery Technologies Limited - Dormant Projects 45 Aurigene Discovery Technologies Limited - Locations And Subsidiaries 46 Head Office 46 Other Locations & Subsidiaries 46 Appendix 47 Methodology 47 Coverage 47 Secondary Research 47 Primary Research 47 Expert Panel Validation 47 Contact Us 47 Disclaimer 48
List of Tables
Aurigene Discovery Technologies Limited, Key Information 6 Aurigene Discovery Technologies Limited, Key Facts 6 Aurigene Discovery Technologies Limited - Pipeline by Indication, 2016 8 Aurigene Discovery Technologies Limited - Pipeline by Stage of Development, 2016 10 Aurigene Discovery Technologies Limited - Monotherapy Products in Pipeline, 2016 11 Aurigene Discovery Technologies Limited - Partnered Products in Pipeline, 2016 12 Aurigene Discovery Technologies Limited - Partnered Products/ Combination Treatment Modalities, 2016 13 Aurigene Discovery Technologies Limited - Out-Licensed Products in Pipeline, 2016 14 Aurigene Discovery Technologies Limited - Out-Licensed Products/ Combination Treatment Modalities, 2016 15 Aurigene Discovery Technologies Limited - IND/CTA Filed, 2016 16 Aurigene Discovery Technologies Limited - Preclinical, 2016 17 Aurigene Discovery Technologies Limited - Discovery, 2016 18 Aurigene Discovery Technologies Limited - Pipeline by Target, 2016 38 Aurigene Discovery Technologies Limited - Pipeline by Route of Administration, 2016 39 Aurigene Discovery Technologies Limited - Pipeline by Molecule Type, 2016 40 Aurigene Discovery Technologies Limited - Pipeline Products by Mechanism of Action, 2016 42 Aurigene Discovery Technologies Limited - Recent Pipeline Updates, 2016 43 Aurigene Discovery Technologies Limited - Dormant Developmental Projects,2016 45 Aurigene Discovery Technologies Limited, Other Locations 46 Aurigene Discovery Technologies Limited, Subsidiaries 46
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
